Table 1 Characteristics of the population according to REIN classification (n = 462*) and our classification (n = 465): (n(%) or mean ± SD)
From: Determinants of urgent start dialysis in a chronic kidney disease cohort followed by nephrologists
USD according REIN classification | Dialysis start according our classification | ||||||
|---|---|---|---|---|---|---|---|
Yes n = 94 (20.3) | No n = 368 (79.5) | p value | Urgent n = 80 (17.2) | Suboptimal n = 73 (15.7) | Planned n = 312 (67.1) | p value | |
Sex (male) | 66 (70.2) | 241 (65.5) | 0.39 | 52 (65.0) | 48 (65.8) | 210 (67.3) | 0.91 |
Age (years) | 67.0 ± 14.4 | 67.2 ± 14.7 | 0.91 | 66.3 ± 15.1 | 68.6 ± 12.4 | 67.0 ± 14.9 | 0.82 |
BMI (kg/m2, 62**) | 26.2 ± 6.8 | 26.7 ± 7.2 | 0.43 | 25.9 ± 8.1 | 27.6 ± 8.4 | 26.5 ± 6.5 | 0.31 |
Initial nephropathy | |||||||
- Chronic glomerulonephritis | 15 (15.8) | 44 (12.0) | 14 (17.5) | 3 (4.1) | 42 (13.5) | ||
- Diabetic nephropathy | 27 (28.4) | 96 (26.2) | 20 (25.0) | 25 (34.2) | 78 (25.1) | ||
- Interstitial chronic nephropathy | 1 (1.1) | 12 (3.3) | 2 (2.5) | 3 (4.1) | 9 (2.9) | ||
- Nephroangiosclerosis | 29 (30.5) | 96 (26.2) | 20 (25.0) | 21 (28.8) | 84 (27) | ||
- Polycystic kidney disease | 5 (5.3) | 40 (10.9) | 6 (8.0) | 6 (8.2) | 34 (10.9) | ||
- Others and undetermined nephropathy | 8 (1.7) | 46 (10.0) | 10 (2.2) | 8 (1.7) | 36 (7.7) | ||
- Urological nephropathy | 9 (9.5) | 34 (9.3) | 9 (11.1) | 6 (8.2) | 29 (9.3) | ||
History | |||||||
- Ischemic cardiomyopathy | 8 (8.5) | 39 (10.6) | 0.55 | 36 (45.0) | 39 (53.4) | 120 (38.4) | 0.05 |
- Diabetes | 55 (58.5) | 144 (39.1) | 0.01 | 7 (8.8) | 8 (11.0) | 32 (10.3) | 0.89 |
- Cardiac failure | 50 (53.2) | 121 (32.9) | 0.0003 | 40 (50.0) | 30 (41.1) | 101 (32.4) | 0.01 |
- Stroke | 19 (20.2) | 31 (8.4) | 0.001 | 17 (21.3) | 8 (11.0) | 26 (8.3) | 0.004 |
- Cancer | 20 (21.3) | 82 (22.3) | 0.83 | 19 (23.8) | 14 (19.2) | 71 (22.8) | 0.76 |
- Current smoker | 10 (10.6) | 45 (12.2) | 0.67 | 9 (11.3) | 6 (8.2) | 41 (13.1) | 0.51 |
- Peripheral arteriopathy | 28 (29.8) | 79 (21.5) | 0.09 | 17 (21.3) | 20 (27.4) | 71 (22.8) | 0.63 |
- IS | 18 (19.2) | 54 (14.7) | 0.29 | 18 (22.5) | 12 (16.4) | 42 (13.5) | 0.13 |
- COPD | 18 (19.2) | 46 (12.5) | 0.10 | 14 (17.5) | 10 (13.7) | 40 (12.8) | 0.56 |
Number of nephrology consultations prior dialysis start | 4.5 ± 1.9 | 5.7 ± 2.0 | < 0.0001 | 4.2 ± 1.8 | 4.7 ± 2.0 | 5.9 ± 2.4 | < 0.0001 |
Dialysis start with a CVC | 78 (83.0) | 65 (21.0) | < 0.0001 | 80 (100) | 59 (83.1) | 6 (2.3) | < 0.0001 |
Peritoneal dialysis vs. HD | 1 (1.1) | 137 (37.2) | < 0.0001 | 0 | 5 (6.9) | 133 (42.6) | < 0.0001 |
ESA (2**) | 74 (79.6) | 295 (80.4) | 0.86 | 37 (45.6) | 23 (32.9) | 158 (51.3) | 0.02 |
RASB (7**) | 35 (37.6) | 182 (50.3) | 0.03 | 65 (80.2) | 57 (78.1) | 249 (80.0) | 0.86 |
Number of antihypertensive drugs (7**) | 2.6 ± 1.4 | 2.7 ± 1.3 | 0.79 | 2.7 ± 1.5 | 2.5 ± 1.4 | 2.7 ± 1.3 | 0.61 |